Skip to content

Clinical study of acupoint submerged thread therapy in the treatment of insulin-resistant metabolism-related fatty liver disease

Clinical study of acupoint submerged thread therapy in the treatment of insulin-resistant metabolism-related fatty liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093556
Enrollment
Unknown
Registered
2024-12-06
Start date
2024-05-06
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism-related fatty liver disease

Interventions

Sponsors

Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated with Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the Chinese and Western medical diagnostic criteria for metabolism-related fatty liver disease and have insulin resistance; (2) Age >=18 and <=60 years old, gender is not limited; (3) The test subjects did not use drugs related to the treatment of fatty liver within 4 weeks; (4) Voluntarily participate in this trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Except for other causes of fatty liver disease, such as alcohol, viral infections, autoimmune hepatitis, and drugs; (2) Past or present loss of liver function or hepatocellular liver cancer; (3) Suffering from severe skin disease, severe diabetes and low absorption and repair function of skin and subcutaneous tissue caused by various diseases; (4) People with allergies and scarring; (5) Test subjects with cardiovascular, pulmonary, renal and other serious primary diseases; (6) Patients with combined complications of diabetes; (7) Pregnant or lactating patients; (8) Patients with mental illness, patients with speech communication disorders.

Design outcomes

Primary

MeasureTime frame
Insulin Resistance Index;

Secondary

MeasureTime frame
Fasting blood sugar;Fasting insulin;Triglyceride;High density lipoprotein ;Low density lipoprotein ;Small dense Low density lipoprotein;Alanine aminotransferase;Aspartate transaminase;Gamma glutamyltransferase;Magnetic resonance imaging-proton density fat fraction;

Countries

China

Contacts

Public ContactLi Jing

Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated with Shanghai University of Traditional Chinese Medicine

LIJINGacu@126.com+86 189 3056 8565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026